This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Welcome to AOHP 2014 National Conference Agenda page. 

Start planning now to attend the 2014 AOHP National Conference in New Orleans from September 10-13, 2014. It is never too early to make plans and to ensure that your time and expenses are budgeted to attend. If you need help to justify your conference attendance with your supervisor, contact AOHP Headquarters for assistance in articulating the value at info@aohp.org. Online Registration is now open:  http://AOHPconference.com.

Conference official site    Download conference brochure

View your personal schedule, browse what’s happening right now or search for what you want. The mobile web app stores the schedule data locally on your phone for offline access too. Bookmark on your phone by visiting http://aohp2014nationalconference.sched.org/mobile.

View analytic
Thursday, September 11 • 11:20am - 12:20pm
A003 Drug Diversion and Impairment: Implications for Everyone (Intermediate)

Sign up or log in to save this to your schedule and see who's attending!

Topic Overview:

Occupational health professionals have a key role to play in drug diversion detection and response. Through lecture, power point and case study analysis, this presentation will define the scope of the drug diversion problem in healthcare facilities across the United States. Essential components of a diversion surveillance, detection and response program will be discussed, including relevant policies, the benefits of internal and external collaboration, and staff education. Drug diversion measures for healthcare facilities will also be reviewed, from pre-employment screening and surveillance to drug testing, handling and security, as well as diversion response. The presenter will also highlight related regulatory requirements from the Controlled Substance Act, the FDA and other public health institutions. Specific methods for protecting patients and facilities when diversion occurs will also be examined.



  1. Define the scope of healthcare facility drug diversion in the United States.
  2. Identify the essential components of a diversion surveillance, detection and response program.
  3. Describe basic drug diversion measures healthcare facilities should undertake.
  4. Outline the diversion-related regulatory requirements with which healthcare facilities must comply.
  5. Evaluate methods of protecting patients and institutions when diversion occurs.

avatar for Kimberly S. New, JD, BSN, RN

Kimberly S. New, JD, BSN, RN

Kimberly S. New works at a large academic medical center where she manages controlled substance surveillance, diversion detection and regulatory reporting. She also serves as a consultant and resource to healthcare facilities across the country. New is regularly involved with diversion risk analyses, diversion education, development of institutional policies and procedures, and diversion investigation support. She is currently partnering with... Read More →

Thursday September 11, 2014 11:20am - 12:20pm
Napoleon Ballroom 3/F

Attendees (13)